U.S. flag An official website of the United States government
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. Product Identifiers under the Drug Supply Chain Security Act - Questions and Answers
  1. Regulatory Information

GUIDANCE DOCUMENT

Product Identifiers under the Drug Supply Chain Security Act - Questions and Answers September 2018

Draft

Not for implementation. Contains non-binding recommendations.

Product Identifiers under the Drug Supply Chain Security Act - Questions and Answers

Issued by:
Guidance Issuing Office
Center for Drug Evaluation and Research
Center for Biologics Evaluation and Research

This draft guidance  is intended  to address anticipated questions  regarding  product identifiers that are required  under section 582 of  the Federal Food,  Drug, and Cosmetic  Act (FD&C  Act) (21 U.S.C. 360eee-1), as amended by the Drug Supply  Chain  Security  Act (DSCSA) (Title II of Public Law 113-54) for packages and homogenous cases of certain drug products.


Submit Comments

Submit comments on this guidance document electronically via docket ID: FDA-2013-S-0610 - Specific Electronic Submissions Intended For FDA's Dockets Management Staff (i.e., Citizen Petitions, Draft Proposed Guidance Documents, Variances, and other administrative record submissions)

If unable to submit comments online, please mail written comments to:

Division of Dockets Management (HFA- 305)
Food and Drug Administration
5630 Fishers Lane, Rm. 1061
Rockville, MD 20852

All comments should be identified with the title of the guidance.